ClinicalTrials.gg
Not yet recruitingNCT07420504SuSleepUpdated Jul 10, 2026

A Longitudinal Study of Parental Sleep Intervention for Behavioral Insomnia in Early Childhood

An interventional study of Parental sleep enhancement intervention in Behavioural Insomnia of Childhood, sponsored by Children's Hospital of Soochow University. Not yet recruiting at 1 site in China. Open to participants aged 6 Months to 36 Months. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Children's Hospital of Soochow University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
6 Months to 36 Months
Sex
All
01

Study summary

The global incidence of mental illness among children and adolescents is rising, drawing increasing attention to early risk factors and preventive strategies. Behavioral sleep problems, which affect up to 50% of infants in the local population, are closely linked to impaired self-regulation-a core factor underlying many psychological disorders and a promising target for early intervention. Enhancing self-regulation may not only alleviate sleep problems but also mitigate long-term mental health risks. This study aims to develop an intervention toolkit based on current guidelines and high-quality evidence, integrating parent education with dynamic sleep assessment and longitudinal evaluation of self-regulation in infants. The project seeks to establish the efficacy of this approach, identify moderators of intervention outcomes, and provide an evidence base for personalized sleep interventions in clinical practice.

02

Conditions studied

  • Behavioural Insomnia of Childhood

Browse trials for

Keywords

  • infant
  • sleep intervention
  • clinical cohort
  • toddler
  • self-regulation
03

In context

Self-Control

168 studies on the registry are indexed under Self-Control; 22 are open to participants now.

This study's planned enrollment of 30 is below the median of 88 across 144 interventional studies indexed under Self-Control.

Browse Self-Control studies →

Lead sponsor

Children's Hospital of Soochow University is the lead sponsor of 6 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 36 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 6-36 months
  2. Diagnosed with behavioural insomnia (sleep latency > 20 minutes and/or ≥ 2 nighttime awakenings per night, each lasting at least 5 minutes)
  3. Daytime functional impairment (eg., excessive sleepiness, inattention, emotional problems)
  4. Parental consent for participation

Exclusion criteria

Exclusion Criteria:

  1. Chronic diseases
  2. History of head trauma
  3. Other primary sleep disorders (e.g., obstructive sleep disorder, narcolepsy, restless leg syndrome)
  4. Developmental delay, epilepsy, or other neurological/metabolic disorders
  5. Participation in a new intervention program within the past 4 weeks, and/or initiation of new medication within the past 4 weeks.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    infants and toddlers with behavioural insomnia

    Session 1 * Baseline feedback: Interpret parental sleep reports, actigraphy, and questionnaire data. * Daily schedule adjustment: Review current routines and guide age-appropriate daily adjustments. * Sleep environment modification: Introduce optimal sleep environment settings. * Bedtime routine development:Demonstrate how to establish an individualised bedtime routine . * Putting to bed drowsy but awake: Introduce signals of sleepiness and highlight the principle. * Graduated extinction: Detailed guidance on graduated extinction, in which parents delay responding to children's nighttime crying. * Parental rehearsal: Conduct parental rehearsal and provide tracking booklets with sleep diaries. Session 2 * Implementation review: Assess implementation feedback and troubleshoot barriers. * Sleep education: Deliver education on paediatric sleep architecture and developmental impacts. * Individualized adjustment: Provide tailored protocol modifications based on individual feedback.

    Behavioral: Parental sleep enhancement intervention

Interventions

  • BehavioralParental sleep enhancement intervention

    The sleep intervention toolkit for this project is designed based on relevant research and guidelines. Two structured parental intervention sessions, each lasting 2 hours, will be conducted by qualified paediatricians in an intervention room within the Department of Child Health. The first session will be held within 2 weeks after the baseline evaluation, followed by the second session 2 weeks later. Up to 3 caregivers per child may attend, at least one of whom must be a parent. Each session will accommodate a maximum of three families. Adherence to the intervention will be enhanced through health education on child sleep, sharing each child's sleep status to guide tailored intervention plans, as well as providing timely sleep and developmental reports during the intervention and at each follow-up visit.

06

What researchers measure

Primary outcomes

  1. Sleep efficiency (SE) measured by Actigraphy

    Sleep efficiency is defined as the percentage of total sleep time (sleep period determined by the actigraphy) to the total time spent in bed (from the time children go to bed to the time they finally get up in the morning). A higher percentage reflects more continuous and higher-quality sleep. As SE is closely related to SOL and nighttime awakings, it is selected as the primary outcome of the current study.Through the built-in accelerometer and other sensors, the actigraphy can be used to monitor an individual's activity level and sleep situation, thereby analysing the child's sleep patterns such as sleep efficiency. The team technician will export the relevant sleep indicators recorded by the actigraphy and calculate relevant outcome measures. Moreover, the actigraphy is validated with parental records of sleep diaries.

    Time frame: Baseline, 1 month, 6 months and 12 months

Secondary outcomes

  1. Sleep onset latency (SOL) measured by Actigraphy

    In this study, SOL serves as the indicator of sleep initiation difficulty, with a threshold exceeding 20 minutes indicating prolonged sleep onset. Improvement in SOL (i.e., shortened latency) following the intervention will suggest enhanced self-regulation capacity and reduced reliance on parental assistance at bedtime. Moreover, the actigraphy is validated with parental records of sleep diaries.

    Time frame: Baseline, 1 month, 6 months and 12 months

  2. Wake after sleep onset (WASO) measured by Actigraphy

    Wake after sleep onset (WASO) is defined as the total duration of wakefulness between initial sleep onset and final morning awakening. Longer WASO indicates poorer nighttime sleep quality. Improvements (reductions) following intervention indicate better sleep consolidation. Moreover, the actigraphy is validated with parental records of sleep diaries.

    Time frame: Baseline, 1 month, 6 months, and 12 months

  3. The number of nighttime awakenings (NW) measured by Actigraphy

    The number of nighttime awakenings (NW) refers to the total number of awakening events lasting more than 5 minutes per night. A frequency of two or more awakenings per night may indicate poor nighttime sleep quality. This indicator will be reported to assess the degree of fragmentation of nighttime sleep. Improvements (reductions) following intervention indicate better sleep consolidation. Moreover, the actigraphy is validated with parental records of sleep diaries.

    Time frame: Baseline, 1 month, 6 months and 12 months

  4. Subjective sleep quality measured by the Brief Infant Sleep Questionnaires (BISQ)

    BISQ is a parent-reported instrument designed to screen for sleep problems in infants and toddlers. This study will use the standardised Chinese version, which covers multiple aspects of early childhood sleep, including sleep onset conditions, total sleep duration, nighttime awakenings, co-sleeping, and overall sleep patterns.

    Time frame: Baseline, 1 month, 6 months, and 12 months

  5. Subjective sleep quality measured by the Infant/Toddler Sleep Assessment Scale (ISAS/TSAS)

    ISAS and TSAS were developed and validated by the Provincial Research Working Group of Chinese Infant and Toddler Sleep Assessment Scale for children aged 4-11 months and 12-35 months, respectively. Total scores, derived from all items, reflect sleep quality, with responses rated on a four-point Likert scale of 1 to 4. Higher scores indicate poorer sleep quality.

    Time frame: Baseline, 1 month, 6 months, and 12 months

  6. Self-regulation ability measured by the Age and Stage Questionnaires: Social and Emotional-2 (ASQ:SE-2)

    The ASQ:SE-2 is an internationally recognised developmental screening tool for assessing social-emotional development in children aged 1 to 72 months. The questionnaire assesses a child's development across 7 specific behavioural dimensions: 1. Self-Regulation: ability to calm or settle themselves. 2. Compliance: ability to follow rules and respond to limits. 3. Social-Communication: use of gestures, sounds, and words to interact with others. 4. Adaptive Functioning: ability to manage daily routines like eating, sleeping, and toileting. 5. Autonomy: ability to act independently and demonstrate self-confidence. 6. Affect: expression of feelings and emotions. 7. Interpersonal interaction: ability to engage with parents, other adults and children. A higher score indicates more concerning behaviours.

    Time frame: Baseline, 1 month, 6 months, and 12 months

Other outcomes

  1. Maternal excessive daytime sleepiness measured by the Epworth Sleepiness Scale (ESS)

    Maternal daytime sleepiness will be assessed using the Epworth Sleepiness Scale (ESS), an 8-item self-reported questionnaire employing a 4-point Likert scale of 0 to 3. It measures how likely a person is to doze off or fall asleep in 8 common, sedentary situations of daily life. Higher scores indicate greater daytime sleepiness, with a score of 10 or above indicating excessive daytime sleepiness.

    Time frame: Baseline, 1 month, 6 months, and 12 months

  2. Maternal mental health measured by the World Health Organisation Five Well-Being Index (WHO-5)

    Maternal mental health will be assessed using the World Health Organization Five Well-Being Index (WHO-5), a 5-item self-reported questionnaire employing a 6-point Likert scale of 0 to 5. These items reflect positive mood, vitality, and general interests over the preceding 14 days. Higher scores indicate greater well-being.

    Time frame: Baseline, 1 month, 6 months and 12 months

  3. Maternal parenting stress measured by the Parenting Stress Index-Short Form (PSI-SF)

    Maternal parenting stress will be assessed using the Parenting Stress Index-Short Form (PSI-SF), a 36-item parent-reported questionnaire consisting of three subscales including parental distress, parent-child dysfunctional interaction, and difficult child. The total score ranges from 36 to 180. A score of 85 or less indicates a normal level of parental stress. A score between 86 and 90 represents a critically high level. A score greater than 90 suggests a high level of parental stress, and a score of 99 or above indicates an extremely high level of parental stress.

    Time frame: Baseline, 6 months and 12 months

  4. Maternal occupational stress measured by the Chinese Version of Copenhagen Psychosocial Questionnaire (COPSOQ)

    Maternal occupational stress will be assessed using the short version of the Copenhagen Psychosocial Questionnaire (COPSOQ), a 44-item self-reported questionnaire consisting of eight subscales. Higher scores in the job demands and job insecurity subscales reflect greater occupational stress, whereas higher scores in the personal impact and development, interpersonal relationships and leadership, and job satisfaction subscales indicate lower levels of occupational stress.

    Time frame: Baseline and 12 months

  5. Maternal life satisfaction measured by the Satisfaction With Life Scale (SWLS)

    Maternal life satisfaction will be assessed using the Satisfaction With Life Scale (SWLS), a 5-item self-reported questionnaire employing a 7-point Likert scale of 1 to 7. Higher scores indicate greater perceived life satisfaction.

    Time frame: Baseline and 12 months

  6. Mother-child relationship measured by the Postpartum Bonding Questionnaire (PBQ)

    Mother-child bonding will be assessed using the Postpartum Bonding Questionnaire (PBQ), a 25-item self-reported questionnaire employing a 6-point Likert scale of 0 to 5. Higher scores indicate greater impairment in the mother-child relationship.

    Time frame: Baseline and 12 months

  7. Family functioning measured by the Family APGAR Index (APGAR)

    Maternal satisfaction with family functioning will be assessed using the Family APGAR Index (APGAR), a 5-item self-reported questionnaire employing a 3-point Likert scale of 0 to 2. Scores range from 0 to 10, with higher scores indicating better family functioning (0-3 = highly dysfunctional, 4-6 = moderately dysfunctional, 7-10 = highly functional).

    Time frame: Baseline and 12 months

  8. Child temperament measured by the Carey Children Temperament Questionnaire Series

    Child temperament will be assessed using age-appropriate version of scales, including the Revised Infant Temperament Questionnaire (RITQ) for infants aged 5 to 11 months, and the Toddler Temperament Scale (TTS) for children aged 1 to 3 years. Both questionnaires assess nine subscales: rhythmicity, adaptability, approach, intensity, mood, activity, threshold, distractibility, and persistence.

    Time frame: Baseline and 12 months

  9. Child neurodevelopment measured by the Chinese Developmental Scale for Children Aged 0-6 years (CDSC-II)

    Child neurodevelopment will be assessed using the Chinese Developmental Scale for Children Aged 0-6 Years (2nd Edition) (CDSC-II). This scale evaluates five subscales: gross motor, fine motor, adaptive ability, language, and social behaviour, comprising a total of 261 items across 28 age-in-months groups. The development quotient will be used to determine subscale-specific and overall development status, with lower scores signifying developmental vulnerability.

    Time frame: Baseline, 6 months and 12 months

07

Study locations

1 site
  • Childrens' Hospital of Soochow University
    Suzhou, Jiangsu, China
08

References and documents

Individual participant data

Plan to share: No — The individual participant data collected in this study will not be made available for sharing. The informed consent obtained from the participants does not include provision for public data sharing. To protect participant privacy and confidentiality, and in accordance with the ethical approvals governing this study, the data will be kept securely by the research team and will not be deposited in a public repository.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Aug 2028, 24 months later.

Of 104 non-industry interventional studies with no phase under Self-Control, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 34. This study's planned 24 months is above that.

Counting every sponsor, half of 105 studies reached it within 16 months; a quarter within 5 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2026
First posted
Feb 19, 2026
StartEst.
Aug 2026
Primary completionEst.
Aug 2028
CompletionEst.
Aug 2028
Last update
Jul 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07420504
Lead sponsor
Children's Hospital of Soochow University
Responsible party
Tingyu Rong (Resident/Assistant research fellow, Children's Hospital of Soochow University) — Principal investigator
First posted
Feb 19, 2026
Start date
Aug 2026 (estimated)
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Jul 10, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion